|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: Globocan 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
2
|
Taghizadeh-Kermani A, Yahouiyan SZ,
AliAkbarian M and Seilanian Toussi M: Prognostic significance of
metastatic lymph node ratio in patients with gastric cancer: an
evaluation in North-East of Iran. Iran J Cancer Prev. 7:73–79.
2014.PubMed/NCBI
|
|
3
|
D’Angelo G, Di Rienzo T and Ojetti V:
Microarray analysis in gastric cancer: A review. World J
Gastroenterol. 20:11972–11976. 2014. View Article : Google Scholar
|
|
4
|
Aderem A and Ulevitch RJ: Toll-like
receptors in the induction of the innate immune response. Nature.
406:782–787. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Takeda K and Akira S: Toll-like receptors
in innate immunity. Int Immunol. 17:1–14. 2005. View Article : Google Scholar
|
|
6
|
Oldenburg M, Krüger A, Ferstl R, Kaufmann
A, Nees G, Sigmund A, et al: TLR13 recognizes bacterial 23S rRNA
devoid of erythromycin resistance-forming modification. Science.
337:1111–1115. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Merrell MA, Ilvesaro JM, Lehtonen N, Sorsa
T, Gehrs B, Rosenthal E, Chen D, Shackley B, Harris KW and Selander
KS: Toll-like receptor 9 agonists promote cellular invasion by
increasing matrix metalloproteinase activity. Mol Cancer Res.
4:437–447. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Berger R, Fiegl H, Goebel G, Obexer P,
Ausserlechner M, Doppler wW, et al: Toll-like receptor 9 expression
in breast and ovarian cancer is associated with poorly
differentiated tumors. Cancer Sci. 101:1059–1066. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schmausser B, Andrulis M, Endrich S, Lee
SK, Josenhans C, Müller-Hermelink HK, et al: Expression and
subcellular distribution of toll-like receptors TLR4, TLR5 and TLR9
on the gastric epithelium in Helicobacter pylori infection. Clin
Exp Immunol. 136:521–526. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmausser B, Andrulis M, Endrich S,
Müller-Hermelink HK and Eck M: Toll-like receptors TLR4, TLR5 and
TLR9 on gastric carcinoma cells: an implication for interaction
with Helicobacter pylori. Int J Med Microbiol. 295:179–185. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wang X, Xue L, Yang Y, Xu L and Zhang G:
TLR9 promoter polymorphism is associated with both an increased
susceptibility to gastric carcinoma and poor prognosis. PLoS One.
8:e657312013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wagner H: The immunobiology of the TLR9
subfamily. Trends Immunol. 25:381–386. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Koti M, Gooding RJ, Nuin P, Haslehurst A,
Crane C, Weberpals J, et al: Identification of the
IGF1/PI3K/NFkB/ERK gene signalling networks associated with
chemotherapy resistance and treatment response in high-grade serous
epithelial ovarian cancer. BMC Cancer. 13:5492013. View Article : Google Scholar
|
|
14
|
Zhan Z, Xie X, Cao H, Zhou X, Zhang XD,
Fan H, et al: Autophagy facilitates TLR4- and TLR3-triggered
migration and invasion of lung cancer cells through the promotion
of TRAF6 ubiquitination. Autophagy. 10:257–268. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ma YJ, Cui L, Zhang YL and Li XP:
Correlations of TLR9 to clinicopathologic features of gastric
cancer. J Ningxia Med Univ. 34:126–128. 2012.
|
|
16
|
Romero-Calvo I, Ocón B, Martínez-Moya P,
Suárez MD, Zarzuelo A, Martínez-Augustin O and de Medina FS:
Reversible Ponceau staining as a loading control alternative to
actin in Western blots. Anal Biochem. 401:318–320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li MZ, Deng L, Wang JJ, Xiao LB, Wu WH,
Yang SB and Li WF: Surgical outcomes and prognostic factors of T4
gastric cancer patients without distant metastasis. PLoS One.
9:e1070612014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang JQ, Jeelall YS, Ferguson LL and
Horikawa K: Toll-like receptors and cancer: MYD88 mutation and
inflammation. Front Immunol. 5:367–377. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ilvesaro JM, Merrell MA, Swain TM,
Davidson J, Zayzafoon M, Harris KW and Selander KS: Toll like
receptor-9 agonists stimulate prostate cancer invasion in vitro.
Prostate. 67:774–781. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ren T, Xu L, Jiao S, Wang Y, Cai Y, Liang
Y, Zhou Y, Zhou H and Wen Z: Tlr9 signaling promotes tumor
progression of human lung cancer cell in vivo. Pathol Oncol Res.
15:623–630. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Krieg AM: CpG motifs in bacterial DNA and
their immune effects. Annu Rev Immunol. 20:709–760. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Latz E, Schoenemeyer A, Visintin A,
Fitzgerald KA, Monks BG, Knetter CF, et al: TLR9 signals after
translocating from the ER to CpG DNA in the lysosome. Nat Immunol.
5:190–198. 2004. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
Maeda S: NF-κB, JNK, and TLR signaling
pathways in hepatocarcinogenesis. Gastroenterol Res Pract.
367694:2010.
|
|
24
|
Kakiuchi Y, Tsuji S, Tsujii M, Murata H,
Kawai N, Yasumaru M, et al: Cyclooxygenase-2 activity altered the
cell-surface ca- rbohydrate antigens on colon cancer cells and
enhanced liver metastasis. Cancer Res. 62:1567–1572.
2002.PubMed/NCBI
|
|
25
|
Chen R, Alvero AB, Silasi DA, Steffensen
KD and Mor G: Cancers take their Toll - the function and regulation
of Toll-like receptors in cancer cells. Oncogene. 27:225–233. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jezierska A and Motyl T: Matrix
metalloproteinase-2 involvement in breast cancer progression: a
mini-review. Med Sci Monit. 15:RA32–RA40. 2009.PubMed/NCBI
|
|
27
|
Sims JD, McCready J and Jay DG:
Extracellular heat shock protein (Hsp)70 and Hsp90α assist in
matrix metalloproteinase-2 activation and breast cancer cell
migration and invasion. PLoS One. 6:e188482011. View Article : Google Scholar
|
|
28
|
Okayama H, Kumamoto K, Saitou K, Hayase S,
Kofunato Y, Sato Y, et al: CD44v6, MMP-7 and nuclear Cdx2 are
significant biomarkers for prediction of lymph node metastasis in
primary gastric cancer. Oncol Rep. 22:745–755. 2009.PubMed/NCBI
|
|
29
|
Yeh YC, Sheu BS, Cheng HC, Wang YL, Yang
HB and Wu JJ: Elevated serum matrix metalloproteinase-3 and -7 in
H. pylori-related gastric cancer can be biomarkers correlating with
a poor survival. Dig Dis Sci. 55:1649–1657. 2010. View Article : Google Scholar
|
|
30
|
Sugie S, Tsukino H, Mukai S, Akioka T,
Shibata N, Nagano M and Kamoto T: Cyclooxygenase 2 genotypes
influence prostate cancer susceptibility in Japanese men. Tumour
Biol. 35:2717–2721. 2014. View Article : Google Scholar
|
|
31
|
Lu J, Li XF, Kong LX, Ma L, Liao SH and
Jiang CY: Expression and significance of cyclooxygenase-2 mRNA in
benign and malignant ascites. World J Gastroenterol. 19:6883–6887.
2013. View Article : Google Scholar : PubMed/NCBI
|
